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Pharmaceuticals have been present in our world’s waters since humans began 
experimenting with medicines; however, product propagation and ready access to 
pharmaceuticals coupled with burgeoning human population have significantly 
increased the loading of these compounds into the environment. Pharmaceutically 
active compounds (PhACs) are considered to produce a biological activity on 
humans and animals. Drugs manufacturing processes lead to release of toxic organic 
compounds and their metabolites into the environment. Safety and toxicology stud-
ies have used to investigate the side effects of pharmaceuticals on human and animal 
health. Treatment processes can and do reduce the concentrations of pharmaceuti-
cals in water, however, the degree of efficacy is often a function of chemical struc-
ture, cost, and energy. All treatment processes have some degree of side effects, such 
as generation of residuals or by-products. This paper provides a concise report on 
removal of PhACs by recent advances oxidation processes (AOPs) where hydroxyl 
radicals (HO.) acts as a common oxidant and the improvement of biodegradability 
to a level amicable for subsequent biological treatment.
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1. Introduction
Pharmaceutical compounds are released widely into the environment without 
proper treatment. Proper elimination of Pharmaceutically active compound 
(PhACs) present in aquatic system plays an important role for preventing of 
diseases both in humans and animals. PhACs are structurally complex in nature and 
these organic compounds have some intrinsic characteristics so that treatment of 
drug contaminated water using conventional treatment processes namely, mem-
brane-based separations, adsorption, ion-exchange and biological treatment are not 
that efficient for the industrial applications [1]. Researchers have been continuously 
working to progress technically, environmentally and economically comprehensive 
treatment techniques.
To quantify the impact of PhACs on the environment several attempts have been 
made in the past few years. Low levels of PhACs including antibiotics, analgesics, 
anti-depressants, beta-blockers, and hormones & hormone mimics are detected in 
Environmental Issues and Sustainable Development
2
surface, ground and drinking water resources apart from wastewater effluent Globe 
[2]. However, the removal efficiency is highly variable, and it can be substantially 
less than 100%. Carballa et al. (2005) suggested that due to their relatively long 
environmental half-life, many PhACs may be accumulated to the measurable 
levels in aquatic ecosystems. Concentrations of PhACs were found to be less than 
one ppb, while the combined concentrations beat ppm ranges [2]. These drugs are 
highly active and interactive with receptors in humans and animals and are toxic in 
nature towards health threatening organisms such as bacteria, fungi and parasites. 
Moreover, human and animal health are affected by various types of organisms and 
also targeted by PhACs. Therefore, PhACs may have some potential effect on the 
aquatic and terrestrial organisms [3]. They are usually uncovered as waste for a long 
time. Therefore, many scientists have started to discover the effects of organisms to 
various PhACs [4]. Some drugs like an analgesic and anti-inflammatory are uni-
versal for their applicability in the medical field and in effluents of WWTPs. They 
are discharge recipient water at concentrations range of μg/L. For an example, the 
concentration of diclofenac is found in WWTP as 1.4 μg/L [5].
Due to presence of carboxylic moieties (-COOH) and one or two phenolic 
hydroxyl groups (-OH) most of these types of drugs are acidic in nature. Antibiotics 
are used generally to prevent bacterial infections and they are used in veterinary 
applications as food additives at sub-therapeutic doses to treat food efficiency and 
promote growth [6]. Carballa et al. [7] reported that wide application of antibiotics 
may lead to bacterial resistances. The occurrence of different drugs in sewage sludge 
of WWTPs and surface is well reported [8, 9]. Common PhACs present in various 
industrial effluents is summarized in Table 1.
2. Sources of PhACs in water and wastewater
2.1 Agriculture and agriculture industry
Variety of PhACs made from recombinant proteins potentially has greater 
efficacy and fewer side effects than small organic molecules [10]. Bacteria or yeast 
commonly produced the recombinant proteins [11]. However, pharming does 
not require expensive for the production of proteins or their metabolic products. 
Also, the production capacity can be rapidly climbed up to meet the demand. It is 
projected that the expense of producing a recombinant protein via pharming will be 






Suspended solids, mg/L 300–400
Volatile acids, mg/L 50–80
Alkalinity as CaCO3, mg/L 50–100
Phenols, mg/L 65–72
Table 1. 
Characteristics of pharmaceutical industry wastewater producing allopathic medicines [2].
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extensive pollution are found in agricultural industry. Overflow from agricultural 
fields often contains fertilizers, eroded soil, pesticides and pharmaceuticals that 
could able to form a major source of water pollution [13].
2.2 Health care facilities
Varieties of antibiotics have been isolated from urban and hospital wastewater 
[14]. It has been found that they simply could pass through aquatic environment 
and be transferred to surface water [15]. Kim and Tanaka [16] suggested that both 
wastewater treatment processes and the microbial ecology in surface water were 
disturbed by antibiotics and disinfectants.
Chang et al. [17] found different PhACs including analgesics, beta-blockers, 
non-steroidal anti-inflammatories, alpha-antidepressants, anti-cancer drugs, anti-
fungal agents, opiates, antibiotics, anti-coagulants, diuretics, anti-anginals, anti-
diabetics and hypolipidemics are detected by in hospitals effluents. Unregulated 
disposal of unused and expired medicines is the primary inception of PhACs into 
the environment from hospitals and health care facilities [17]. Rejection of syringe 
into the hospital drain off after application on the patient’s body also an important 
source of PhACs is [18].
Figure 1. 
Pathways for inception of pharmaceuticals and their metabolites in the environment [20].
Parameters Typical values
Drinking water, μg/L 0.3
Surface water, μg/L 2
Ground water, μg/L 1
Municipal sewage (treated), μg/L 10
Biosolids (treated), μg/kg 10000
Agricultural soils, μg/kg 10
Table 2. 
Concentrations of pharmaceuticals in water and solid wastes [2].
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2.3 Surface water and ground water
Due to incomplete elimination pharmaceutical products, the residues of these 
products can enter the aquatic environment [19]. The typical concentration of 
PhACs in water and solid wastes is summarized in Table 1. However, the concentra-
tion in untreated industrial wastewater varies from ppb to ppm levels. Different 
pathways for initiation of pharmaceuticals and their metabolites in the environment 
are shown in Figure 1. The typical values of different parameters of pharmaceutical 
industry wastewater are shown in Table 2.
3. Techniques for treatment of pharmaceutical wastewater
3.1 Adsorption technique
The efficiency of adsorption process is studied by numerous workers for treat-
ment of wastewater containing varieties of drugs. Especially the porosity and 
surface area of adsorbent shows the extent of adsorption [19]. Dutta et al. [21] 
reported that both adsorption and desorption efficiency of 6-aminopenicillanic 
acid (6-APA) in aqueous effluent using activated carbon as an adsorbent was found 
to be 93% and the process is highly reversible in nature. About greater than 90% of 
oestrogens is removed from both powdered activated carbon (PAC) (5 mg/L) and 
granular activated carbon (GAC) can remove [22]. However, dissolved organic com-
pounds (DOC), surfactants and humic acids participate with binding sites to block 
the pores within activated carbon structures [22]. A filtration step is important to 
increase removal efficiency before treating micro pollutants using PAC [23, 24].
High molecular weight compounds reduce the blocking of micropores that leads 
to decrease in carbon demand. Thus, PAC will be suitable for the treatment of pre-
treated effluent with a low organic loading [23]. Separation of fine carbon particles 
is the general difficulty with PAC treatment. An additional step of separation is 
usually needed such as sedimentation, which necessitates the use of precipitants, or 
via (membrane) filtration.
3.2 Membranes processes
Membrane-based separation methods like MBR (membrane bioreactor), 
MBR/RO (MBR followed by reverse osmosis) and UF/RO (ultra-filtration fol-
lowed by RO) are used for the removal of PhACs from wastewater [22]. Maeng 
et al. [25] suggested that PhACs like ibuprofen, naproxen, caffeine and acet-
aminophen and can be expressively removed using MBR and the degradation 
efficiency can be as high as 82%. However, the adaptation of microorganisms to 
less degradable compounds can occur due to its enhanced sludge retention time 
(SRT) in MBRs. MBR treatment has a better performance (removal >80%) than 
the conventional processes for diclofenac, ketoprofen, ranitidine, gemfibrozil, 
bezafibrate, pravastatin and ofloxacin. Chang et al. [17] obtained about 95% 
COD and 99% BOD reduction from a 10 m3 per day capacity MBR operated at 
a pharmaceutical facility. Nano filtration (NF) and RO membranes are more 
efficient in eliminating PhACs having different physico-chemical properties. The 
removal using NF is mostly over 85%, except for gemfibrozil (50.2%), bezafibrate 
(71.8%), atenolol (66.6%), mefenamic acid (30.2%) and acetaminophen (43%) 
[26]. Short circuiting of membrane or failure of membrane support is responsible 
for the reduction of permeate quality. However, the retentate must be treated 
further to degrade the more concentrated form of PhACs.
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3.3 Biological treatment
These processes use to remove contaminants by assimilating them and it has 
long been a support of wastewater treatment in chemical industries using bacteria 
and other microorganisms. In any biological system, the main factor is the supply of 
an adequate oxygen as cells need not only organic materials as food but also oxygen 
to breathe. A wide range of natural and xenobiotic chemicals in pharmaceutical 
wastewater are recalcitrant and non-biodegradable in nature. Anaerobic processes 
are not always effective in removing such substances [23]. Conventional activated 
sludge treatment (AST) with a long hydraulic retention time (HRT) generally is the 
choice for pharmaceutical industry wastewater [27]. It needs a lower capital cost 
than advanced treatment methods and a limited operational requirement. However, 
it suffers from the production of large amounts of sludge [22]. Removal efficiencies 
are decreased due to development of more resistant microorganisms towards many 
PhACs [28]. Ibuprofen, naproxen, bezafibrate and estrogens (estrone, estradiol and 
ethinylestradiol) showed a high degree of removal while sulfamethoxazole, carba-
mezapine and diclofenac displayed limited removal efficiency [29]. A few studies 
are carried out using sequence batch reactors (SBRs) and MBRs to improve the 
efficiency of AST [29]. Ileri et al. [30] achieved removal efficiency of 82% bio-
chemical oxygen demand (BOD), 88% chemical oxygen demand (COD), 96% NH3 
and 98% suspended solids (SS) from domestic and pharmaceutical wastewater in a 
SBR operated for 4 h aeration followed by 60 min sedimentation. In another study, 
slightly lower COD removal efficiencies between 63 and 69% are reported [31]. 
MBRs are known to be effective for the removal of bulk organics and can replace 
traditional methods when operated in combination with a conventional AST [32]. 
The main advantage of MBRs over AST is that they require less space and can also 
treat variable wastewater compositions [17]. Biologically active filters are also used 
for pharmaceutical wastewater treatment and can remove PhACs [33].
3.4 Advanced oxidation processes (AOPs)
Advanced Oxidation Processes (AOPs) those are generating the very reactive 
radicals, such as hydroxyl radicals (HO•) which are able to react with most of the 
organic compounds. The pollutants and by-products are degraded through a series 
of complex reactions. In the first step, HO• radicals react with organic compounds 
through electron transfer leading to formation of organic intermediates and after 
that species react with dissolved oxygen to form peroxyl (ROO•) radicals which 
undergo rapid decomposition. The overall process leads to partial or total mineral-
ization of pollutants [34].
3.4.1 Fenton processes (FP)
Fenton’s reagent, a mixture of Fe2+ (catalyst) and hydrogen peroxide (H2O2) 
which produces HO• radical, a strong oxidizing agent (E0 = 2.8 vs. NHS). The 
mechanism of FP is studied by several workers [17, 35]. The main reactions occur-
ring in Fenton oxidation of organics are appended bellow (Eqs. 1–4):
 2 3 •
2 2
Fe H O Fe OH HO
+ + −+ → + +   (1)
 2 • 3Fe HO Fe OH+ + −+ → +   (2)
 • •
2
HO RH H O R+ → +   (3)
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 • 3 2R Fe R Fe+ + ++ → +   (4)
where, R• is alkyl free radical.
The major parameters like solution pH, amount of ferrous ion, concentration of 
H2O2, initial concentration of pollutants/ PhACs and presence of other background 
ions [36] that are affecting FP. The optimum pH for FP generally ranges from 2 to 
4. At pH > 4, Fe2+ ions are unstable, and they are easily transformed to Fe3+ forming 
complexes with hydroxyl ion. Moreover, under alkaline conditions H2O2 loses its 
oxidative power as it breakdowns to water [17]. An effluent pH was Adjusted usu-
ally before addition of Fenton reagent. Increase of Fe2+ ions and H2O2 concentration 
boosts up the degradation rate [37]. The use of excess amount of H2O2 can dete-
riorate the overall degradation efficiency of FP coupled with biological treatment 
due to toxic nature of H2O2 to microorganisms [38]. Fenton oxidation of organics/
PhACs can be inhibited by PO4
3−, SO4
2−, F−, Br− and Cl− ions. The inhibition may be 
due to precipitation of iron, scavenging of HO• radicals or coordination with Fe3+ to 
form a less reactive complex [39].
3.4.2 Photo-Fenton processes (PFP)
Photo-Fenton process (H2O2/Fe
2+/UV) involves formation of HO• radicals 
through photolysis of hydrogen peroxide (H2O2/UV) by UV-irradiation along with 
the Fenton reaction (H2O2/Fe
2+). In presence of UV irradiation, ferric ions (Fe3+) are 
also photo-catalytically converted to ferrous ions (Fe2+) with formation of addi-
tional HO• radicals (Eq. 5) [40].
 ( ) 2 •
2
Fe OH h Fe HO
+ ++ ν→ +   (5)
Likewise, PFP gives faster rates and higher degree of mineralization compared 
to conventional FP [39]. The reaction can be driven by low energy photons and it 
also can be achieved using solar irradiation [39]. The employment of solar light 
significantly reduces the operational cost. Another important advantage of PFP is 
that iron-organic complexes formed during Fenton oxidation can be broken under 
the illumination of UV light [41].
3.4.3 UV/H2O2 photolysis (UVP)
UVP includes H2O2 injection with continuous mixing in a reactor equipped with 
UV irradiation system (wavelength 200 to 280 nm). UV light is used to cleave O-O 
bond of H2O2 forming HO
• radicals. The reactions describing UVP are presented 
below (Eqs. 6–11) [42]:
 •
2 2
H O h 2HO+ ν→   (6)
 • •
2 2 2 2
H O HO H O+ →ΗΟ +   (7)
 • •
2 2 2 2 2
H O HO H O H+ΗΟ → + +   (8)
 •
2 2
2HO H O→   (9)
 •
2 2 2 2
2HO H O O→ +   (10)
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HO H O O+ΗΟ → +   (11)
Reaction 6 is the rate limiting because the rates of other reactions are much 
higher. In UVP, a higher initial H2O2 concentration produces higher HO
• radical 
concentration (Eq. 6), which decomposes the target compounds. However, an 
optimal H2O2 concentration exists because overdosing of H2O2 leads to reaction with 
HO• radicals leaving off HO2
• (Eq. 7). UVP is quite efficient in mineralizing PhACs 
[42]. A disadvantage of UVP is that it cannot utilize solar light as the source of UV 
illumination. The required UV irradiation for the photolysis of H2O2 is not available 
in the solar spectrum [43]. H2O2 has poor UV absorption characteristics and input 
irradiation to the reactor is wasted if the water matrix absorbs UV light.
3.4.4 UV/TiO2 photo catalysis (UVPC)
Photocatalysis is the acceleration of a photoreaction using a catalyst in presence of 
light/photon. It is a well-recognized approach where light energy is employed to excite 
the semiconductor material producing electron (e−cb)/hole (h
+
vb) pair (Eq. 12) which 
eventually involves in the detoxification of pollutants (in water or air). e−cb from the 
valence band (VB) is promoted to the conduction band (CB) of the semiconductor 
and a h+vb is created in the VB. The photo generated e
− migrates to the surface without 
recombination can reduce and oxidize the contaminants adsorbed on the surface of 
the semiconductor [44]. e−cb react with surface adsorbed molecular oxygen to yield 
superoxide radical anions (Eq. 13), while h+vb react with water to form HO
•
ad radicals 
on the surface of the catalyst (Eq. 14) [45].
 
2 cb vb
TiO h e h




− −+ →   (13)
 •
vb 2 ad
h H O H HO
+ ++ → +   (14)
TiO2 is widely used as a photocatalyst due to high photo-catalytic activity, low 
cost, low toxicity, high oxidation power, easy availability and chemical stability 
under UV light (λ˂380 nm) [46]. TiO2 has two common crystal structures i.e., rutile 
and antase. TiO2 Degussa 25 consisting of 20% rutile and 80% anatase is considered 
as a standard photocatalyst. Organic compounds can undergo oxidative degradation 
through reactions with h+vb, HO
•
ad, and O2
−• radicals as well as through reductive 
cleavage by e−cb. The key advantages of UVPC are treatment at ambient conditions, 
lower mass transfer limitations using nanoparticles and possibility of use of solar 
irradiation. UVPC is capable for destruction of a wide range of organic chemicals 
into harmless compounds such as CO2 and H2O [47]. The major factors affecting 
UVPC are initial pollutant load, amount of catalyst, reactor design, irradiation 
time, temperature, solution pH, light intensity and presence of ionic species. The 
use of excess catalyst may reduce the amount of photon transfer into the medium 
due to opacity offered by the catalyst particles [36]. The design of reactor should 
assure uniform irradiation of the catalyst [48].
3.5 Advantages and limitations of AOPs
AOPs using H2O2 and Fe
2+ suffer from the requirement of acidic conditions, 
interference by inorganic ions, iron-organic complexation and formation of 
iron sludge. Some of the above limitations can be overcome when heterogeneous 
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photocatalytic treatments like UVPC is used. However, uniform illumination of UV 
light and separation of catalyst particles could limit the application. Application of 
artificial UV light increases the cost of treatment and also poses health hazard to the 
working personnel.
The typical advantages of iron based AOPs are:
i. The process is capable to destroy a wide variety of organic compounds even 
without formation of toxic intermediates.
ii. It offers a cost-effective source of HO• radicals using easy-to-handle reagents.
iii. In FP and PFP, both oxidation and coagulation take place simultaneously.
iv. Effective in destruction of refractory PhACs to improve biodegradability and 
produce an effluent that can be treated biologically as a finishing step.
4. Conclusions
AOPs undergo through different reacting systems such as homogeneous or 
heterogeneous phases and in light or dark. It causes consecutive unselective deg-
radation of organic materials. Complete mineralization occurs even at very low 
concentration and the byproducts formed may be environmentally non-hazardous. 
Biological treatment is recognized as the cheapest available technology to remove 
and degrade organic contaminants. However, advanced separation technology gives 
very inefficient degradation of PhACs because they are usually resistant to biodeg-
radation and characterized by low BOD/COD ratio. Partial Fenton oxidation yields 
more biodegradable products together with the destruction of inhibitory effect 
towards microorganisms in the downstream biological treatment. It also increases 
the overall treatment efficiencies compared to the efficiency of individual process. 
AOPs can be employed for the detoxification of PhACs until the biodegradability is 
improved to a level amicable for subsequent biological treatment.
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